Loading clinical trials...

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT04848220

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

The purpose of this study is to determine whether intravenous temanogrel is a safe and effective treatment for microvascular obstruction (MVO) in adult participants undergoing percutaneous coronary in...

Lead sponsor: Pfizer•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITING

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

NCT06795035 · ST Elevation Myocardial Infarction, Coronary Microvascular Dysfunction, and more

Not Yet RecruitingNA

Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II

NCT06909578 · Microvascular Obstruction (MVO), STEMI - ST Elevation Myocardial Infarction

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 12, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment29

Start dateMay 2021

Last updatedDec 12, 2023

Condition

Microvascular Obstruction

Locations shown

Tibor Rubin VA Medical Center

Long Beach, California

VA Palo Alto - Cardiac Catheterization Laboratory

Palo Alto, California

University of Chicago Medical Center

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions